Adeno-associated virus 9-mediated airway expression of antibody protects old and immunodeficient mice against influenza virus

Clinical and Vaccine Immunology

Volumn 21, Issue 11, 2014, Pages 1528-1533

  Adam, Virginie S ^a,c   Crosariol, Marco ^a   Kumar, Sachin ^a,d   Ge, Moyar Q ^b   Czack, Sarah E ^a   Roy, Soumitra ^a,e   Haczku, Angela ^b   Tretiakova, Anna ^a   Wilson, James M ^a   Limberis, Maria P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c American Association for Cancer Research   (United States)

^d INDIAN INSTITUTE OF TECHNOLOGY GUWAHATI   (India)

^e CRUCELL HOLLAND BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; FIREFLY LUCIFERASE; INFLUENZA VIRUS ANTIBODY FI6; LUCIFERIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; DRUG CARRIER; NEUTRALIZING ANTIBODY;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 9; AGED; AIRBORNE INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DISTRESS SYNDROME; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG EFFICACY; DRUG SCREENING; DRUG SYNTHESIS; FEMALE; GENE DOSAGE; IMMUNE DEFICIENCY; INFECTION PREVENTION; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A VIRUS (A/PUERTO RICO/8/1934(H1N1)); INFLUENZA VACCINATION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; SINGLE DRUG DOSE; VIRUS LOAD; VIRUS STRAIN; WEIGHT REDUCTION; ANIMAL; BIOLOGICAL THERAPY; DEPENDOPARVOVIRUS; DISEASE MODEL; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOCOMPROMIZED PATIENT; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INTRANASAL DRUG ADMINISTRATION; ORTHOMYXOVIRIDAE INFECTIONS; PROCEDURES; SCID MOUSE; SURVIVAL; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BIOLOGICAL THERAPY; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; FEMALE; IMMUNIZATION, PASSIVE; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICE, INBRED BALB C; MICE, SCID; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84914671395     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00572-14     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention. 2010. Estimates of deaths associated with seasonal influenza: United States, 1976-2007. MMWR Morb. Mortal. Wkly. Rep. 59(33):1057-1062.
2. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB. 2007. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25:5086-5096. http://dx.doi.org/10.1016/j.vaccine.2007.03.046.
3. Oliveira EC, Lee B, Colice GL. 2003. Influenza in the intensive care unit. J. Intensive Care Med. 18:80-91. http://dx.doi.org/10.1177/0885066602250368.
4. Dorshkind K, Montecino-Rodriguez E, Signer RA. 2009. The ageing immune system: is it ever too old to become young again? Nat. Rev. Immunol. 9:57-62. http://dx.doi.org/10.1038/nri2471.
5. Ljungman P. 2012. Vaccination of immunocompromised patients. Clin. Microbiol. Infect. 18(Suppl 5):S93-S99. http://dx.doi.org/10.1111/j.1469 -0691.2012.03971.x.
6. Balazs AB, Chen J, Hong CM, Rao DS, Yang L, Baltimore D. 2012. Antibodybased protection against HIV infection by vectored immunoprophylaxis. Nature 481:81-84. http://dx.doi.org/10.1038/nature10660.
7. Johnson PR, Schnepp BC, Zhang J, Connell MJ, Greene SM, Yuste E, Desrosiers RC, Clark KR. 2009. Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys. Nat. Med. 15:901-906. http://dx.doi.org/10.1038/nm.1967.
8. Balazs AB, Bloom JD, Hong CM, Rao DS, Baltimore D. 2013. Broad protection against influenza infection by vectored immunoprophylaxis in mice. Nat. Biotechnol. 31:647-652. http://dx.doi.org/10.1038/nbt.2618.
9. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, Vachieri SG, Pinna D, Minola A, Vanzetta F, Silacci C, Fernandez-Rodriguez BM, Agatic G, Bianchi S, Giacchetto-Sasselli I, Calder L, Sallusto F, Collins P, Haire LF, Temperton N, Langedijk JP, Skehel JJ, Lanzavecchia A. 2011. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333:850-856. http://dx.doi.org/10.1126/science.1205669.
10. Limberis MP, Adam VS, Wong G, Gren J, Kobasa D, Ross TM, Kobinger GP, Tretiakova A, Wilson JM. 2013. Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza. Sci. Transl. Med. 5:187ra172. http://dx.doi.org/10.1126/scitranslmed.3006299.
11. Limberis MP, Racine T, Kobasa D, Li Y, Gao GF, Kobinger G, Wilson JM. 2013. Vectored expression of the broadly neutralizing antibody FI6 in mouse airway provides partial protection against a new avian influenza A virus, H7N9. Clin. Vaccine Immunol. 20:1836-1837. http://dx.doi.org/10.1128/CVI.00545-13.
12. Glamann J, Burton DR, Parren PW, Ditzel HJ, Kent KA, Arnold C, Montefiori D, Hirsch VM. 1998. Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque. J. Virol. 72:585-592.
13. Limberis MP, Wilson JM. 2006. Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proc. Natl. Acad. Sci. U. S. A. 103:12993-12998. http://dx.doi.org/10.1073/pnas.0601433103.
14. Nieto K, Stahl-Hennig C, Leuchs B, Muller M, Gissmann L, Kleinschmidt JA. 2012. Intranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaques. Hum. Gene Ther. 23:733-741. http://dx.doi.org/10.1089/hum.2011.202.
15. Thompson MG. 2013. Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States, February 2013. MMWR Morb. Mortal. Wkly. Rep. 62(07):119-123.
16. Wu H, Haist V, Baumgartner W, Schughart K. 2010. Sustained viral load and late death in Rag2-/- mice after influenza A virus infection. Virol. J. 7:172. http://dx.doi.org/10.1186/1743-422X-7-172.
17. Garraud O, Borhis G, Badr G, Degrelle S, Pozzetto B, Cognasse F, Richard Y. 2012. Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond. BMC Immunol. 13:63. http://dx.doi.org/10.1186/1471-2172-13-63.
18. Lee N, Shin MS, Kang I. 2012. T-cell biology in aging, with a focus on lung disease. J. Gerontol. A Biol. Sci. Med. Sci. 67:254-263. http://dx.doi.org/10.1093/gerona/glr237.
19. Jiang J, Fisher EM, Murasko DM. 2011. CD8 T cell responses to influenza virus infection in aged mice. Ageing Res. Rev. 10:422-427. http://dx.doi.org/10.1016/j.arr.2011.02.001.
20. Pica N, Langlois RA, Krammer F, Margine I, Palese P. 2012. NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge. J. Virol. 86:10293-10301. http://dx.doi.org/10.1128/JVI.01131-12.